Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

SARS-CoV-2 Omicron Variant AI-based Primers

View ORCID ProfileCarmina A. Perez-Romero, View ORCID ProfileAlberto Tonda, View ORCID ProfileLucero Mendoza-Maldonado, View ORCID ProfileJohn MacSharry, View ORCID ProfileJoanna Szafran, View ORCID ProfileEric Claassen, View ORCID ProfileJohan Garssen, View ORCID ProfileAletta D. Kraneveld, View ORCID ProfileAlejandro Lopez-Rincon
doi: https://doi.org/10.1101/2022.01.21.475953
Carmina A. Perez-Romero
2Departamento de Investigación, Universidad Central de Queretaro (UNICEQ), Av. 5 de Febrero 1602, San Pablo, 76130 Santiago de Querétaro, Qro., Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carmina A. Perez-Romero
Alberto Tonda
3UMR 518 MIA-Paris, INRAE, c/o 113 rue Nationale, 75103, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Tonda
Lucero Mendoza-Maldonado
4Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”. Salvador Quevedo y Zubieta 750, Independencia Oriente, C.P. 44340 Guadalajara, Jalisco, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucero Mendoza-Maldonado
John MacSharry
8School of Microbiology and School of Medicine, University College Cork, College Rd, University College, Cork, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John MacSharry
Joanna Szafran
8School of Microbiology and School of Medicine, University College Cork, College Rd, University College, Cork, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joanna Szafran
Eric Claassen
5Athena Institute, Vrije Universiteit, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Claassen
Johan Garssen
1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands
6Department Immunology, Danone Nutricia research, Uppsalalaan 12, 3584 CT Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johan Garssen
Aletta D. Kraneveld
1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aletta D. Kraneveld
Alejandro Lopez-Rincon
1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, the Netherlands
7Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alejandro Lopez-Rincon
  • For correspondence: alejandro.lopezrn@hotmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

As the COVID-19 pandemic continues to affect the world, a new variant of concern, B.1.1.529 (Omicron), has been recently identified by the World Health Organization. At the time of writing, there are still no available primer sets specific to the Omicron variant, and its identification is only possible by using multiple targets, checking for specific failures, amplifying the suspect samples, and sequencing the results. This procedure is considerably time-consuming, in a situation where time might be of the essence. In this paper we use an Artificial Intelligence (AI) technique to identify a candidate primer set for the Omicron variant. The technique, based on Evolutionary Algorithms (EAs), has been already exploited in the recent past to develop primers for the B.1.1.7/Alpha variant, that have later been successfully tested in the lab. Starting from available virus samples, the technique explores the space of all possible subsequences of viral RNA, evaluating them as candidate primers. The criteria used to establish the suitability of a sequence as primer includes its frequency of appearance in samples labeled as Omicron, its absence from samples labeled as other variants, a specific range of melting temperature, and its CG content. The resulting primer set has been validated in silico and proves successful in preliminary laboratory tests. Thus, these results prove further that our technique could be established as a working template for a quick response to the appearance of new SARS-CoV-2 variants.

Competing Interest Statement

J. Garssen is a part time employee at Danone Nutricia Research, Utrecht, the Netherlands.

Footnotes

  • ↵* a.lopezrincon{at}uu.nl

  • https://github.com/steppenwolf0/omicronVariant

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 26, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 Omicron Variant AI-based Primers
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 Omicron Variant AI-based Primers
Carmina A. Perez-Romero, Alberto Tonda, Lucero Mendoza-Maldonado, John MacSharry, Joanna Szafran, Eric Claassen, Johan Garssen, Aletta D. Kraneveld, Alejandro Lopez-Rincon
bioRxiv 2022.01.21.475953; doi: https://doi.org/10.1101/2022.01.21.475953
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 Omicron Variant AI-based Primers
Carmina A. Perez-Romero, Alberto Tonda, Lucero Mendoza-Maldonado, John MacSharry, Joanna Szafran, Eric Claassen, Johan Garssen, Aletta D. Kraneveld, Alejandro Lopez-Rincon
bioRxiv 2022.01.21.475953; doi: https://doi.org/10.1101/2022.01.21.475953

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Bioinformatics
Subject Areas
All Articles
  • Animal Behavior and Cognition (3506)
  • Biochemistry (7348)
  • Bioengineering (5324)
  • Bioinformatics (20266)
  • Biophysics (10020)
  • Cancer Biology (7744)
  • Cell Biology (11306)
  • Clinical Trials (138)
  • Developmental Biology (6437)
  • Ecology (9954)
  • Epidemiology (2065)
  • Evolutionary Biology (13325)
  • Genetics (9361)
  • Genomics (12587)
  • Immunology (7702)
  • Microbiology (19027)
  • Molecular Biology (7444)
  • Neuroscience (41049)
  • Paleontology (300)
  • Pathology (1230)
  • Pharmacology and Toxicology (2138)
  • Physiology (3161)
  • Plant Biology (6861)
  • Scientific Communication and Education (1273)
  • Synthetic Biology (1897)
  • Systems Biology (5313)
  • Zoology (1089)